Report of the PMDA-ATC GCP inspection in MRCT Webinar 2022 for FDA Philippines

PMDA held the GCP inspection in Multi-Regional Clinical Trial (MRCT) Webinar for the Food and Drug Administration, the Republic of the Philippines (FDA Philippines) on December 6, 2022.

This webinar was designed for regulators of pharmaceutical products in the FDA Philippines and counted 32 participants.

In the webinar, a PMDA staff from Office of Non-clinical and Clinical Compliance gave a lecture and case study on GCP Inspections. A Q&A session was also held to enhance understanding of the topic.

The PMDA continuously makes efforts to strengthen collaboration with the FDA Philippines through projects such as the PMDA-ATC for Pharmaceuticals and Medical Devices Regulatory Affairs.

See attached program